The 3 Things That Matter for Johnson & Johnson Now

Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies by market capitalization. The drugmaker has diversified operations, generating consistent revenue and profits.However, Johnson & Johnson has lagged the market in recent years due to a combination of factors, leading some investors to question whether it's still a solid long-term pick. Looking at some critical company-specific developments may help answer that question. Let's review three key factors to keep in mind.Johnson & Johnson has been dealing for years with thousands of lawsuits related to its talc-based products, which plaintiffs claim gave them cancer. This issue has somewhat affected the drugmaker's brand name and image. Although it has attempted to settle most of these lawsuits in court through a bankruptcy maneuver, its efforts have been rejected by several judges. The longer J&J's legal fights last, the worse the issue becomes for the company. Investors should monitor developments related to this challenge.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool